Th17 cells stimulate tumor residential cells to produce CCL2 and CCL20, which provokes the recruitment of dendritic cell, granulocyte, CD4+ T cell, CD8+ T cell, and NK cell to the tumor site [99]. The gene discussed is CCL20; the disease is neoplasm.